As of October 22, 2026, EPN / Euphorinol is illegal to sell at retail in Maryland as edible / ingestible. EPN edible illegal in Maryland - semi-synthetic cannabinoid barred outright by the Sec. 36-1102(c) not-naturally-occurring ban. Controlling source: Md. Alc. Bev. & Cannabis Sec. 36-1102 (Ch. 57 / HB 12, 2025) - not-naturally-occurring cannabinoid ban + 0.5 mg total-THC serving threshold.
Verified October 22, 2026 (hash check) · confidence: confirmedSame synthetic-cannabinoid ban as the vape form: Md. Alc. Bev. & Cannabis Sec. 36-1102(c) bars selling or distributing 'a cannabinoid product that is not derived from naturally occurring biologically active chemical constituents.' EPN is semi-synthetic, so the ban reaches an EPN edible even though its COA shows no THC and even if it were routed through the MCA licensed cannabis channel - the license cures a dose problem, not a synthetic-origin problem. The 0.5 mg total-THC/serving, 2.5 mg/package cap (Sec. 36-1102(b)) is a THC-axis limit EPN would slip on the non-detect panel; the not-naturally-occurring ban is dispositive.
A person may not sell or distribute a cannabinoid product that is not derived from naturally occurring biologically active chemical constituents.
As of October 22, 2026, EPN / Euphorinol is illegal to sell at retail in Maryland as vape / inhalable. EPN vape illegal in Maryland - semi-synthetic cannabinoid barred outright by the Sec. 36-1102(c) not-naturally-occurring ban (both forms). Controlling source: Md. Alc. Bev. & Cannabis Sec. 36-1102 (Ch. 57 / HB 12, 2025) - not-naturally-occurring cannabinoid ban + 0.5 mg total-THC serving threshold.
Verified October 22, 2026 (hash check) · confidence: confirmedMd. Alc. Bev. & Cannabis Sec. 36-1102(c) flatly bars selling or distributing 'a cannabinoid product that is not derived from naturally occurring biologically active chemical constituents.' This is a synthetic-cannabinoid prohibition, not a dose threshold - so the Maryland Cannabis Administration (MCA) licensed channel (which routes over-0.5 mg total-THC products) is NOT an escape hatch for a semi-synthetic cannabinoid; a synthetic product cannot be sold even licensed. EPN is semi-synthetic by the maker's own admission, so it falls inside (c) regardless of its non-detect THC panel. The Appellate Court of Maryland (Sept. 2025) confirmed hemp-derived psychoactive products made by a chemical process are prohibited. The 0.5 mg total-THC/serving cap (Sec. 36-1102(b)) is a THC-axis lever EPN reads non-detect on; the not-naturally-occurring ban is dispositive.
A person may not sell or distribute a cannabinoid product that is not derived from naturally occurring biologically active chemical constituents.
| Form | Status | Headline | Verified |
|---|---|---|---|
| Edible / ingestible | Illegal | EPN edible illegal in Maryland - semi-synthetic cannabinoid barred outright by the Sec. 36-1102(c) not-naturally-occurring ban. | 2026-10-22 |
| Vape / inhalable | Illegal | EPN vape illegal in Maryland - semi-synthetic cannabinoid barred outright by the Sec. 36-1102(c) not-naturally-occurring ban (both forms). | 2026-10-22 |
Among Maryland's 5 neighbors, District of Columbia and Delaware are illegal; Virginia and West Virginia are restricted; Pennsylvania is legal.
Map and neighbor comparison show edible / ingestible. Open the interactive map · Every compound in Maryland
Federally restricted. Contested hemp lane now; excluded as semi-synthetic at the Nov 12, 2026 cliff (P.L. 119-37 Sec. 781) Federal detail
4 instruments on file for this compound's framework in Maryland; 4 of 4 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
30c5d8056a7c8ad736-1102. (a) (1) In this section the following words have the meanings indicated. (2) "Hemp" has the meaning stated in Sec. 14-401 of the Agriculture Article. (3) "Tetrahydrocannabinol" means: (i) any tetrahydrocannabinol, including delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol, and delta-10-tetrahydrocannabinol, regardless of how derived; (ii) any other cannabinoid, except cannabidiol that the Administration determines to cause intoxication; and (iii) any other chemically similar compound, substance, derivative, or isomer of tetrahydrocannabinol, as identified by the Administration. (4) "Tincture" means a solution that is: (i) dissolved in alcohol, glycerin, or vegetable oil; and (ii) distributed in a dropper bottle of 4 ounces or less. (b) (1) A person may not sell or distribute a product intended for human consumption or inhalation that contains more than 0.5 milligrams of tetrahydrocannabinol per serving or 2.5 milligrams of tetrahydrocannabinol per package unless the person is licensed under Sec. 36-401 of this title and the product complies with the: (i) manufacturing standards established under Sec. 36-203 of this title; (ii) laboratory testing standards established under Sec. 36-203 of this title; and (iii) packaging and labeling standards established under Sec. 36-203 of this title. (2) A person may not sell or distribute a product described under paragraph (1) of this subsection to an individual under the age of 21 years. (c) A person may not sell or distribute a cannabinoid product that is not derived from naturally occurring biologically active chemical constituents. (d) (1) Notwithstanding subsection (b) of this section and subject to paragraph (2) of this subsection, it is not a violation of this section for a person to sell or distribute a hemp-derived tincture intended for human consumption that contains: (i) a ratio of cannabidiol to tetrahydrocannabinol of at least 15 to 1; and (ii) 2.5 milligrams or less of tetrahydrocannabinol per serving and 100 milligrams or less of tetrahydrocannabinol per package. (2) To sell or distribute a hemp-derived tincture under this subsection, a person must provide, as required by the Administration, tincture samples for the purpose of testing to determine chemical potency and composition levels and to detect and quantify contaminants.
33e5b0ea28a63056SS36-1102. (a)(1) In this section the following words have the meanings indicated. (2) 'Hemp' has the meaning stated in SS14-401 of the Agriculture Article. (3) 'Tetrahydrocannabinol' means: (i) any tetrahydrocannabinol, including delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol, and delta-10-tetrahydrocannabinol, regardless of how derived; (ii) any other cannabinoid, except cannabidiol that the Administration determines to cause intoxication; and (iii) any other chemically similar compound, substance, derivative, or isomer of tetrahydrocannabinol, as identified by the Administration. (4) 'Tincture' means a solution that is: (i) dissolved in alcohol, glycerin, or vegetable oil; and (ii) distributed in a dropper bottle of 4 ounces or less. (b)(1) A person may not sell or distribute a product intended for human consumption or inhalation that contains more than 0.5 milligrams of tetrahydrocannabinol per serving or 2.5 milligrams of tetrahydrocannabinol per package unless the person is licensed under SS36-401 of this title and the product complies with the: (i) manufacturing standards established under SS36-203 of this title; (ii) laboratory testing standards established under SS36-203 of this title; and (iii) packaging and labeling standards established under SS36-203 of this title. (2) A person may not sell or distribute a product described under paragraph (1) of this subsection to an individual under the age of 21 years. (c) A person may not sell or distribute a cannabinoid product that is not derived from naturally occurring biologically active chemical constituents. (d)(1) Notwithstanding subsection (b) of this section and subject to paragraph (2) of this subsection, it is not a violation of this section for a person to sell or distribute a hemp-derived tincture intended for human consumption that contains: (i) a ratio of cannabidiol to tetrahydrocannabinol of at least 15 to 1; and (ii) 2.5 milligrams or less of tetrahydrocannabinol per serving and 100 milligrams or less of tetrahydrocannabinol per package. (2) To sell or distribute a hemp-derived tincture under this subsection, a person must provide, as required by the Administration, tincture samples for the purpose of testing to determine chemical potency and composition levels and to detect and quantify contaminants. (e) A person who violates subsection (b) of this section: (1) may be charged by a citation; and (2) is guilty of a misdemeanor and on conviction is subject to a fine not exceeding $5,000. (f) A person who violates subsection (c) of this section: (1) may be charged by a citation; and (2) is guilty of a misdemeanor and on conviction is subject to a fine not exceeding $10,000.
30c5d8056a7c8ad736-1102. (a) (1) In this section the following words have the meanings indicated. (2) "Hemp" has the meaning stated in Sec. 14-401 of the Agriculture Article. (3) "Tetrahydrocannabinol" means: (i) any tetrahydrocannabinol, including delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol, and delta-10-tetrahydrocannabinol, regardless of how derived; (ii) any other cannabinoid, except cannabidiol that the Administration determines to cause intoxication; and (iii) any other chemically similar compound, substance, derivative, or isomer of tetrahydrocannabinol, as identified by the Administration. (4) "Tincture" means a solution that is: (i) dissolved in alcohol, glycerin, or vegetable oil; and (ii) distributed in a dropper bottle of 4 ounces or less. (b) (1) A person may not sell or distribute a product intended for human consumption or inhalation that contains more than 0.5 milligrams of tetrahydrocannabinol per serving or 2.5 milligrams of tetrahydrocannabinol per package unless the person is licensed under Sec. 36-401 of this title and the product complies with the: (i) manufacturing standards established under Sec. 36-203 of this title; (ii) laboratory testing standards established under Sec. 36-203 of this title; and (iii) packaging and labeling standards established under Sec. 36-203 of this title. (2) A person may not sell or distribute a product described under paragraph (1) of this subsection to an individual under the age of 21 years. (c) A person may not sell or distribute a cannabinoid product that is not derived from naturally occurring biologically active chemical constituents. (d) (1) Notwithstanding subsection (b) of this section and subject to paragraph (2) of this subsection, it is not a violation of this section for a person to sell or distribute a hemp-derived tincture intended for human consumption that contains: (i) a ratio of cannabidiol to tetrahydrocannabinol of at least 15 to 1; and (ii) 2.5 milligrams or less of tetrahydrocannabinol per serving and 100 milligrams or less of tetrahydrocannabinol per package. (2) To sell or distribute a hemp-derived tincture under this subsection, a person must provide, as required by the Administration, tincture samples for the purpose of testing to determine chemical potency and composition levels and to detect and quantify contaminants.
0dc332f2278006ed[MCA bulletin, Sept. 18, 2025:] [The provision applies to products] "containing more than 0.5mg of THC per serving or more than 2.5mg of THC per package" [hemp-derived psychoactive products]; [the State sought to enforce] "§ 36-1102 of the Alcoholic Beverages and Cannabis Article" [...]; [Appellate Court, Sept. 9, 2025:] "delta-8 and delta-10 THC, are now and have always been illegal in Maryland." [ATCC Advisory 24-004: products] "intended for human consumption or inhalation" [over the limits require an] "MCA cannabis license holder" [to sell; violation is a misdemeanor with a fine up to $5,000.] [Statute text not fetched; agency summaries used.]
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap